Heron Therapeutics Inc (HRTX)
2.985
+0.40
(+15.25%)
USD |
NASDAQ |
Apr 23, 14:48
Heron Therapeutics Revenue (Quarterly): 34.23M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 34.23M |
| September 30, 2023 | 31.43M |
| June 30, 2023 | 31.76M |
| March 31, 2023 | 29.62M |
| December 31, 2022 | 30.03M |
| September 30, 2022 | 26.56M |
| June 30, 2022 | 27.63M |
| March 31, 2022 | 23.46M |
| December 31, 2021 | 20.66M |
| September 30, 2021 | 23.23M |
| June 30, 2021 | 22.44M |
| March 31, 2021 | 20.02M |
| December 31, 2020 | 20.60M |
| September 30, 2020 | 19.96M |
| June 30, 2020 | 22.67M |
| March 31, 2020 | 25.40M |
| December 31, 2019 | 35.08M |
| September 30, 2019 | 42.62M |
| June 30, 2019 | 36.66M |
| March 31, 2019 | 31.60M |
| December 31, 2018 | 28.84M |
| September 30, 2018 | 19.79M |
| June 30, 2018 | 17.28M |
| March 31, 2018 | 11.57M |
| December 31, 2017 | 10.05M |
| Date | Value |
|---|---|
| September 30, 2017 | 8.572M |
| June 30, 2017 | 8.51M |
| March 31, 2017 | 3.632M |
| December 31, 2016 | 1.279M |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
19.96M
Minimum
Sep 2020
42.62M
Maximum
Sep 2019
27.58M
Average
26.56M
Median
Sep 2022
Revenue (Quarterly) Benchmarks
| United Therapeutics Corp | 614.70M |
| Esperion Therapeutics Inc | 32.25M |
| Aldeyra Therapeutics Inc | -- |
| Ocular Therapeutix Inc | 14.80M |
| Clearside Biomedical Inc | 6.345M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.72M |
| Total Expenses (Quarterly) | 44.45M |
| EPS Diluted (Quarterly) | -0.05 |
| Enterprise Value | 482.70M |
| Gross Profit Margin (Quarterly) | 71.12% |
| Profit Margin (Quarterly) | -31.33% |
| Earnings Yield | -28.14% |
| Normalized Earnings Yield | -28.14 |